BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35258858)

  • 21. Monocytic AML cells inactivate antileukemic lymphocytes: role of NADPH oxidase/gp91(phox) expression and the PARP-1/PAR pathway of apoptosis.
    Aurelius J; Thorén FB; Akhiani AA; Brune M; Palmqvist L; Hansson M; Hellstrand K; Martner A
    Blood; 2012 Jun; 119(24):5832-7. PubMed ID: 22550344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The Expression and Function of NK Cells in Patients with Acute Myeloid Leukemia].
    Liu L; Chen X; Jin HM; Zhao SS; Zhu Y; Qian SX; Wu YJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Feb; 30(1):49-55. PubMed ID: 35123603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High expression of costimulatory molecules correlates with low relapse-free survival probability in acute myeloid leukemia (AML).
    Graf M; Reif S; Hecht K; Pelka-Fleischer R; Kroell T; Pfister K; Schmetzer H
    Ann Hematol; 2005 May; 84(5):287-97. PubMed ID: 15592672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Expression of Tim-3 on natural killer cells in patients with acute myeloid leukemia and its clinical significance].
    Ma JF; Li CX; Wu DP; Sun ZL; Yan CL
    Zhonghua Xue Ye Xue Za Zhi; 2019 Sep; 40(9):755-758. PubMed ID: 31648478
    [No Abstract]   [Full Text] [Related]  

  • 25. Oligoclonal expansion of TCR Vδ T cells may be a potential immune biomarker for clinical outcome of acute myeloid leukemia.
    Jin Z; Luo Q; Lu S; Wang X; He Z; Lai J; Chen S; Yang L; Wu X; Li Y
    J Hematol Oncol; 2016 Nov; 9(1):126. PubMed ID: 27863523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural killer cell (NK) subsets and NK-like T-cell populations in acute myeloid leukemias and myelodysplastic syndromes.
    Aggarwal N; Swerdlow SH; TenEyck SP; Boyiadzis M; Felgar RE
    Cytometry B Clin Cytom; 2016 Jul; 90(4):349-57. PubMed ID: 26648320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fas receptor-Fas ligand system is independent of both CD34 status and chemosensitivity in acute myeloid leukemia.
    Lewis NR; Pallis M; Russell NH
    Exp Hematol; 2000 May; 28(5):535-42. PubMed ID: 10812243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical and experimental studies of childhood acute myeloid leukemia with 11q23/MLL rearrangements].
    He YX; Xue YQ; Wang HY; Shao XJ; Pan JL; Xu J; Yang NC; Ji ZH; Huang YP; Hu SY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Dec; 29(6):677-82. PubMed ID: 23225048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone marrow-derived mesenchymal stem/stromal cells in patients with acute myeloid leukemia reveal transcriptome alterations and deficiency in cellular vitality.
    Zhang L; Chi Y; Wei Y; Zhang W; Wang F; Zhang L; Zou L; Song B; Zhao X; Han Z
    Stem Cell Res Ther; 2021 Jun; 12(1):365. PubMed ID: 34174939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The expression pattern of CD56 (N-CAM) in human bone marrow biopsies infiltrated by acute leukemia.
    Khanlari B; Buser A; Lugli A; Tichelli A; Dirnhofer S
    Leuk Lymphoma; 2003 Dec; 44(12):2055-9. PubMed ID: 14959847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunoreactivity of MIC2 (CD99) and terminal deoxynucleotidyl transferase in bone marrow clot and core specimens of acute myeloid leukemias and myelodysplastic syndromes.
    Kang LC; Dunphy CH
    Arch Pathol Lab Med; 2006 Feb; 130(2):153-7. PubMed ID: 16454553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune-Based Therapeutic Interventions for Acute Myeloid Leukemia.
    Perna F; Espinoza-Gutarra MR; Bombaci G; Farag SS; Schwartz JE
    Cancer Treat Res; 2022; 183():225-254. PubMed ID: 35551662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Using next generation sequencing technology to analyze gene mutations in patients with acute myeloid leukemia and the impact on prognosis].
    Zhao CX; Wang JM; Li JM; Zou SH; Chen FY; Liang AB; Hou J; Hu XX; Zhang YX; Gu SY; Zhu JY; Li P; Du J; Yang YN; Qin YW; Wang XR; Wang C
    Zhonghua Yi Xue Za Zhi; 2019 Oct; 99(40):3145-3151. PubMed ID: 31694105
    [No Abstract]   [Full Text] [Related]  

  • 34. Single-cell map of diverse immune phenotypes in the acute myeloid leukemia microenvironment.
    Guo R; Lü M; Cao F; Wu G; Gao F; Pang H; Li Y; Zhang Y; Xing H; Liang C; Lyu T; Du C; Li Y; Guo R; Xie X; Li W; Liu D; Song Y; Jiang Z
    Biomark Res; 2021 Mar; 9(1):15. PubMed ID: 33648605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fatty acid metabolism predicts prognosis and NK cell immunosurveillance of acute myeloid leukemia patients.
    Ye Z; Li Y; Tian X; Wei Y; Yu Y; Lai K; Yang K; Qiu Z; Lin J; Zhao M; Lin D; Xu X
    Front Oncol; 2022; 12():1018154. PubMed ID: 36338749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies.
    Graf M; Hecht K; Reif S; Pelka-Fleischer R; Pfister K; Schmetzer H
    Eur J Haematol; 2004 Feb; 72(2):89-106. PubMed ID: 14962246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ex vivo isolation, expansion and bioengineering of CCR7+CD95-/or CD62L+CD45RA+ tumor infiltrating lymphocytes from acute myeloid leukemia patients' bone marrow.
    Cao H; Kim DH; Howard A; Moz H; Wasnik S; Baylink DJ; Chen CS; Reeves ME; Mirshahidi S; Xiao J; Francis O; Marcucci G; Xu Y
    Neoplasia; 2021 Dec; 23(12):1252-1260. PubMed ID: 34775232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An inflammatory state remodels the immune microenvironment and improves risk stratification in acute myeloid leukemia.
    Lasry A; Nadorp B; Fornerod M; Nicolet D; Wu H; Walker CJ; Sun Z; Witkowski MT; Tikhonova AN; Guillamot-Ruano M; Cayanan G; Yeaton A; Robbins G; Obeng EA; Tsirigos A; Stone RM; Byrd JC; Pounds S; Carroll WL; Gruber TA; Eisfeld AK; Aifantis I
    Nat Cancer; 2023 Jan; 4(1):27-42. PubMed ID: 36581735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic impact of Wilms tumor gene mutations in Egyptian patients with acute myeloid leukemia with normal karyotype.
    Zidan MA; Kamal Shaaban HM; Elghannam DM
    Hematology; 2014 Jul; 19(5):267-74. PubMed ID: 24074521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics of NK cells from leukemic microenvironment in MLL-AF9 induced acute myeloid leukemia.
    Yang F; Wang R; Feng W; Chen C; Yang X; Wang L; Hu Y; Ren Q; Zheng G
    Mol Immunol; 2018 Jan; 93():68-78. PubMed ID: 29154208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.